AI, data analysis startup Clarify Health Solutions raises $57M

Clarify's software platform includes consumer engagement apps, patient management tools, and a value-based performance insight generator.
By Dave Muoio
Share

AI-enabled healthcare insights company Clarify Health Solutions announced this morning that it has closed a $57 million Series B financing round led by global investment firm KKR.

According to the announcement, this new funding will primarily support growth at Clarify, which so far has worked with more than 125 systems, payers, and pharmaceuticals to deploy its software at more than 5,000 locations.

“We are thrilled to partner with KKR to build the world’s first real-time care guidance platform,” Dr. Jean Drouin, CEO and cofounder of Clarify, said in a statement. “We are entering a new era, where technology can help us to reimagine care delivery. We have accepted for far too long that an accessible, service-oriented, and customer-centric experience is simply unattainable in health care. We are committed to making the words ‘delightful,’ ‘healed,’ and ‘affordable’ far more common in the healthcare lexicon.”

Clarify Health Solutions (not to be confused with phototherapy company Clarify Medical) offers a digital platform that incorporate predictive analytics and machine learning into the design of care delivery models. Boasting a 20 terabytes of clinical, claims, social determinant, lab, and prescription with which to make its inferences, the company’s offerings help match patients to appropriate and cost-effective care.

The platform is comprised of three primary offerings. Clarify Care Prism looks to provide customers value-based performance insights at the facility, physician, and patient level. Clarify Care Pilot is a patient engagement product that allows patients to view and follow personalized care plans prescribed by practitioners through a mobile or browser-based app. Finally, Clarify Care Connect is a clinician-facing tool that monitors multiple patients using prioritized intervention alerts, patient stratification, and other features.

“Today’s healthcare market is not only very complicated but also extremely fragmented and full of patient dissatisfaction,” Ali Satvat, member of KKR and the head of KKR’s Health Care Strategic Growth investing efforts, said in a statement. “The impressive and highly experienced team at Clarify is addressing this problem by bringing the power of technology to the industry in a way in which it has not been applied to date. We are delighted to partner with Clarify on this effort to enable a more effective, efficient, and, simply, better health care experience for both physicians and the patients who need it.”

Specifically, this new funding will help Clarify expand its clinical, sales, engineering, and data science teams, according to the announcement. It will also allow the company to obtain and incorporate additional data while furthering development of its digital platform.